For the first time, a single electrode targets two brain regions for dual benefit; patient reports a life-changing outcome from 2019 procedure.

Amber Pearson, a 34-year-old resident of Albany, Oregon, has become the world’s first patient to experience life-changing relief from two debilitating conditions, epilepsy, and obsessive-compulsive disorder (OCD), thanks to a pioneering brain implant.

Chris Slatore, M.D., highlights National Lung Cancer Screening Day coinciding with Veteran’s Day, emphasizing the VA's commitment to delivering best-in-class care to veterans: “In 2022, lung cancer took over 130,000 Americans from us, and 8,000 veterans every year are served by the VA who have lung cancer. Those are just not numbers, those are real people."

The Portland Tribune reports on $2 million National Institutes of Health award to OHSU to study environmental influences on children’s respiratory health.

In covering the death of actor Matthew Perry, The Telegraph cites an OHSU study from 2018 noting that even a limited exposure to cocaine can fundamentally alter neuronal circuits in the brain.

A new study recruiting participants for a study at OHSU and two other institutions studying the effects of cannabis use among oncology patients receiving immunotherapy.

A writer for The Atlantic notes that nasal congestion is primarily caused by swelling of nasal tissue within the nose, governed by the nasal cycle. Timothy Smith, M.D., says, “You can blow your nose until the cows come home and you’re not blowing that swollen tissue out.”

In a Medscape story about helping patients to manage pain during gynecologic procedures, Lisa Bayer, M.D., says, “Part of it is just creating a really safe environment of trust as a medical provider.”

WIRED magazine covers the case of an OHSU patient who is the first in the world to benefit from a single stimulator implanted in the brain to effectively control two life-altering conditions: seizures caused by epilepsy and compulsive behavior caused by obsessive-compulsive disorder. Ahmed Raslan, M.D., says, “It was an area that could be targeted with the same electrode.”

Klaus Früh, Ph.D., discusses his research on cytomegalovirus-vectored vaccines for HIV on Microbe TV’s This Week in Virology.